Get the Stockscreener App
1.23
6.03%
0.07
Pre-market:
1.18
-0.05
-4.07%
Gelteq Ltd stock is traded at $1.23, with a volume of 2.07M.
It is up +6.03% in the last 24 hours and up +182.24% over the past month.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
See More
Previous Close:
$1.16
Open:
$1.16
24h Volume:
2.07M
Relative Volume:
0.61
Market Cap:
$13.17M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-3.3324
EPS:
-0.3691
Net Cash Flow:
-
1W Performance:
+155.82%
1M Performance:
+182.24%
6M Performance:
+27.98%
1Y Performance:
-35.60%
1-Day Range:
$1.05
$1.35
1-Week Range:
$0.4872
$2.01
52-Week Range:
$0.387
$2.02
Gelteq Ltd Stock (GELS) Company Profile
Compare GELS vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GELS
Gelteq Ltd
|
1.23 | 12.42M | 0 | 0 | 0 | -0.3691 |
TAK
Takeda Pharmaceutical Co Adr
|
15.66 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.09 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.33 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
548.27 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Gelteq Ltd Stock (GELS) Latest News
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo
Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia
Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa
Gelteq establishes center of excellence in China’s Guangdong - Investing.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com
Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN
GELS - Finviz
Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India
Gelteq secures up to $3.5 million in convertible debt financing - Investing.com
Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - MSN
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
Paul Michael Wynne Net Worth (2026) - GuruFocus
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12%Trending Momentum Stocks - Newser
Gelteq Ltd (GELS) Cash Flow - TradingKey
Will Gelteq Limited (GELS) Stock Outperform Peers | Price at $0.70, Up 3.09%Stock Analysis Community - Newser
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Gelteq Ltd Stock (GELS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):